Re-irradiation of recurrent head and neck carcinomas: Comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Stuschke, Martin ^a,b   Kaiser, Andreas ^b   Abu Jawad, Jehad ^a   Pöttgen, Christoph ^a   Levegrün, Sabine ^a   Farr, Jonathan ^b,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Helical tomotherapy; IMPT; Intensity modulated proton therapy; Plan comparison; Re irradiation; Robust optimization; Robustness

Indexed keywords

ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; ERROR; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PROTON THERAPY; RADIATION DOSE; RADIATION EXPOSURE; RECURRENT CANCER; REPEAT PROCEDURE; TOMOTHERAPY; TREATMENT PLANNING;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROTON THERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84876971338     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-93     Document Type: Article

References (30)

1. Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, Hamoir M, Gery B, Julieron M, Castaing M. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008, 26:5518-5523. 10.1200/JCO.2007.15.0102, 18936479.
2. Langendijk JA, Kasperts N, Leemans CR, Doornaert P, Slotman BJ. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 2006, 78:306-312. 10.1016/j.radonc.2006.02.003, 16524634.
3. Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 2007, 25:4800-4805. 10.1200/JCO.2006.07.9194, 17947728.
4. Tortochaux J, Tao Y, Tournay E, Lapeyre M, Lesaunier F, Bardet E, Janot F, Lusinchi A, Benhamou E, Bontemps P. Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. Radiother Oncol 2011, 100:70-75. 10.1016/j.radonc.2011.06.025, 21741720.
5. Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, Wolden S, Venkatraman ES, Pfister D, Kraus D. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007, 68:731-740. 10.1016/j.ijrobp.2006.12.055, 17379449.
6. Mendenhall NP, Malyapa RS, Su Z, Yeung D, Mendenhall WM, Li Z. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol 2011, 50:763-771. 10.3109/0284186X.2011.590147, 21767172.
7. Van de Water TA, Bijl HP, Schilstra C, Pijls-Johannesma M, Langendijk JA. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist 2011, 16:366-377. 10.1634/theoncologist.2010-0171, 3228110, 21349950.
8. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 2010, 76:S42-S49. 10.1016/j.ijrobp.2009.04.095, 20171517.
9. Ho KF, Fowler JF, Sykes AJ, Yap BK, Lee LW, Slevin NJ. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult. Acta Oncol 2009, 48:431-439. 10.1080/02841860802372272, 18781445.
10. McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys 2011, 80:1292-1298. 10.1016/j.ijrobp.2011.02.014, 21530100.
11. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology [http://www.nccn.org], assessed at Feb 1, 2013, National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.
12. Fredriksson A, Forsgren A, Hardemark B. Minimax optimization for handling range and setup uncertainties in proton therapy. Med Phys 2011, 38:1672-1684. 10.1118/1.3556559, 21520880.
13. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010, 76:S10-S19. 10.1016/j.ijrobp.2009.07.1754, 20171502.
14. Su SF, Huang Y, Xiao WW, Huang SM, Han F, Xie CM, Lu TX. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma. Radiother Oncol 2012, 104:312-316. 10.1016/j.radonc.2012.06.012, 22857858.
15. Albertini F, Hug EB, Lomax AJ. Is it necessary to plan with safety margins for actively scanned proton therapy?. Phys Med Biol 2011, 56:4399-4413. 10.1088/0031-9155/56/14/011, 21709340.
16. Stuschke M, Kaiser A, Pottgen C, Lubcke W, Farr J. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. Radiother Oncol 2012, 104:45-51. 10.1016/j.radonc.2012.03.017, 22560714.
17. Liu W, Zhang X, Li Y, Mohan R. Robust optimization of intensity modulated proton therapy. Med Phys 2012, 39:1079-1091. 10.1118/1.3679340, 3281975, 22320818.
18. Levegrun S, Pottgen C, Abu Jawad J, Berkovic K, Hepp R, Stuschke M. Megavoltage computed tomography image guidance with helical tomotherapy in patients with vertebral tumors: analysis of factors influencing interobserver variability. Int J Radiat Oncol Biol Phys 2012, 85:561-569.
19. Seco J, Panahandeh HR, Westover K, Adams J, Willers H. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty. Int J Radiat Oncol Biol Phys 2012, 83:354-361. 10.1016/j.ijrobp.2011.05.062, 21985941.
20. Muzik J, Soukup M, Alber M. Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases. Med Phys 2008, 35:1580-1592. 10.1118/1.2890085, 18491552.
21. Simone CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol 2011, 101:376-382. 10.1016/j.radonc.2011.05.028, 3174314, 21663988.
22. Taheri-Kadkhoda Z, Bjork-Eriksson T, Nill S, Wilkens JJ, Oelfke U, Johansson KA, Huber PE, Munter MW. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol 2008, 3:4. 10.1186/1748-717X-3-4, 2265732, 18218078.
23. Thorwarth D, Soukup M, Alber M. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison. Radiother Oncol 2008, 86:30-34. 10.1016/j.radonc.2007.11.003, 18061294.
24. Van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, Langendijk JA. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011, 79:1216-1224. 10.1016/j.ijrobp.2010.05.012, 20732761.
25. Widesott L, Pierelli A, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, Di Muzio N, Fazio F, Calandrino R, Schwarz M. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008, 72:589-596. 10.1016/j.ijrobp.2008.05.065, 18793962.
26. Fogliata A, Yartsev S, Nicolini G, Clivio A, Vanetti E, Wyttenbach R, Bauman G, Cozzi L. On the performances of intensity modulated protons, rapidarc and helical tomotherapy for selected paediatric cases. Radiat Oncol 2009, 4:2. 10.1186/1748-717X-4-2, 2672932, 19144155.
27. Nakamura JL, Verhey LJ, Smith V, Petti PL, Lamborn KR, Larson DA, Wara WM, McDermott MW, Sneed PK. Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys 2001, 51:1313-1319. 10.1016/S0360-3016(01)01757-6, 11728692.
28. Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, Chen YH, Chen WY, Wen SY, Chong FC. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol 2012, 104:324-330. 10.1016/j.radonc.2011.11.017, 22236614.
29. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
30. McDonald MW, Moore MG, Johnstone PA. Risk of carotid blowout after reirradiation of the head and neck: a systematic review. Int J Radiat Oncol Biol Phys 2012, 82:1083-1089. 10.1016/j.ijrobp.2010.08.029, 21549520.